All articles by Anthony King
-
ResearchRomans’ hot recipe for self-healing concrete unravelled in Pompeii
Discovery of building materials abandoned at construction site reveals secrets of ancient concrete that can set underwater
-
BusinessUK agrees higher drug prices to secure zero-tariff deal with US
NHS could pay up to 25% more for innovative drugs, but exports will be tariff free for three years
-
NewsSwiss researchers glad to have rejoined EU science schemes but ponder damage of exclusion
The country officially rejoined Horizon Europe and a range of other programmes in November but what did it cost its science base?
-
BusinessAkzoNobel-Axalta merger gives coatings firm extra layers
Pursuit of scale drives continued consolidation across coatings sector
-
BusinessIneos asks EU to intervene over ‘unfair’ chemical imports
Group says 10 key chemicals are being dumped cheaply, harming domestic industry
-
FeatureNitrous oxide emissions accelerate as agriculture drives climate threat
With N2O emissions up 40% in four decades, scientists are searching for answers. Anthony King looks at potential solutions to keep fertiliser nitrogen in the soil
-
ResearchBeer yeast leftovers spun into a promising sustainable yarn 50% stronger than wool
Brewery waste can be turned into a cheap, environmentally-friendly textile
-
BusinessNovartis spends on deals to offset patent losses
$12 billion Avidity acquisition is the latest pipeline-pumping transaction
-
BusinessBASF sells coatings business to Carlyle in €7.7 billion deal
Deal covers automotive and surface treatment businesses and follows earlier sale of decorative paints
-
BusinessNovo Nordisk’s new chief cuts 9000 jobs
Danish firm shifts strategy after struggling to capitalise on its weight loss drugs
-
BusinessPharma sector jolted by unpredictable US tariffs policy
Firms face tough decisions amid Trump’s threatened taxes on pharmaceutical imports and ‘capricious’ approach to tariffs
-
ResearchLow lithium levels linked to Alzheimer’s
Immune cells’ ability to degrade amyloid-beta peptides restored in mice treated with lithium salt
-
NewsAs AI-designed drug looks to pass final hurdle, will this tech change drug discovery forever?
AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI’s impact in pharma
-
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany
-
BusinessUS approves twice yearly injection to prevent HIV
Yeztugo (lenacapavir) provided near-total protection against infection in clinical trials
-
NewsGene-edited crops set to arrive in England, but EU remains divided on them
Crops poised to be grown in England but renegotiation of trade agreement with EU could complicate matters
-
BusinessMilitary demand strains metal supply chains
Conflict and trade disputes have disrupted global supplies of specialist metals like hafnium, antimony and rare earths
-
FeatureHibernation awakens interest for drug discovery
With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways to treat human diseases. Anthony King reports
-
ResearchAn overlooked bonding motif appears in many more proteins than was previously realised
Covalent nitrogen–oxygen–sulfur linkages could be a new target for potential drugs
-
BusinessTrade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns